Intelligence

#Cancer research #Drug discovery

DDW eBook: Breakthroughs in oncology research and drug discovery

This 24-page eBook sponsored by Sino Biological explores the latest innovations in cancer therapeutics and where we can expect the greatest breakthroughs in the future. Download this exclusive eBook to learn more about: The opportunities and advances in cancer research Why liquid biopsies are important in precision medicine trials for… Read More

#DDW eBooks

#Antibodies #Biosimilars #Kinetics #Screening

Fcγ Receptor and Antigen Kinetic Screening for Rapid Biosimilar Downstream Processing Assessment

Demonstrating similarity of biomolecules such as antibodies throughout upstream and downstream production processes is crucial. A rapid testing method is demonstrated using a Humira biosimilar (adalimumab) development sample, which assesses compatibility with three essential ligands in compliance with regulatory standards. This Application Note covers: How to rapidly assess column elution… Read More

#Resources

RNA
#Aarhus University #BioInnovation Institute #mRNA #RNA #Small RNA #Start-ups

smartRNA project joins BII Bio Studio programme

A project focused on developing a small RNA-based platform technology for treating monogenic diseases, smartRNA, has joined the BioInnovation Institute’s (BII) Bio Studio programme. The approach to achieve this involves delivering an engineered small artificial (smart)RNA into the cell, where it assembles with endogenous protein co-factors… Read More

#News #Start-up Zone

#Antibody discovery workflow #Antibody-based therapeutics #Biologics #Monoclonal antibodies

Biologics developability: How Merck creates developability profiles for their mAbs

In this Application Note, discover how the Protein Sciences group at Merck & Co. builds developability profiles for their monoclonal antibody variants. Get an in-depth explanation of the experiments they set up to obtain parameters that help them decide which candidates have the best potential to reach the market, and how they… Read More

#Resources

#Advanced Therapies

DDW Guide: Where is the global innovation in cell & gene therapy?

View the guide and read about:  Recent successes and the current state of the industry Predictions of what to expect going forward in the industry How to tailor CGT therapies for oncology and autoimmune disease Using gene therapy for age-related diseases     Copyright 2022 Drug Discovery World. All Rights… Read More

#DDW Guides

#Cell and gene therapy #Drug development #Drug discovery #Guide

DDW Cell & Gene Therapy Guide 2024

Download the exclusive Guide and read about: Where is the global innovation in CGT and what opportunities is it creating? What does the CGT sector need to overcome challenges and get to market faster? Does the CGT sector have the skills required to ensure future success and of not, how… Read More

#DDW eBooks #DDW Guides

#Drug discovery

Case Study: Streamline Preclinical Drug Discovery: PBMC-Humanised Mouse Models

Discover a clinically predictive and reproducible platform developed by The Jackson Laboratory for simultaneous efficacy and safety assessment. This platform identifies patient-therapy combinations at risk of developing severe inflammatory syndrome, a potentially fatal complication. Optimise the safety profiles of your immunomodulatory therapeutics before first-in-human trials by leveraging this platform. In… Read More

#Case Studies

Singapore skyline
#Asia #Biotech hubs #Market reporting #Singapore

Can Singapore become a global hub for biotech?

With government support and strong academic institutions, does Singapore have what it takes to become a global centre for life sciences? DDW’s Diana Spencer explores how the country is turning pioneering science into a successful biotech industry. Thanks to significant investment by the government into research… Read More

#Exclusive Content #Market Reports

2024 predictions, road forward
#2024 predictions #BioSenic #Cytiva #Monoclonal antibodies #Sphere Fluidics #TrakCel

2024 predictions: Experts comment on monoclonal antibodies 

DDW’s Megan Thomas speaks to experts from the drug discovery industry about their predictions on what 2024 holds for our sector. This is part of a series of predictions based on different themes. Here, experts weigh in on the future of monoclonal antibodies (mAbs).  Amanda Halford, President… Read More

#Exclusive Content #Trends & Analysis

Plant-based concept
#Bio Studio #Bioma #Chronic pain #Mental health #Plant-based #Start-ups

Tackling pain and mental health with plant-based medicines

DDW Editor Reece Armstrong speaks to Michael Krogh Jensen, Co-founder and CEO of Biomia, about developing plant-based medicines and what recent investment and support from the Bio Studio programme means for its pipeline. RA: How has being part of the Bio Studio programme helped you develop your pipeline?… Read More

#Exclusive Content #Start-up Zone

#Drug discovery

App Note: Fcγ Receptor and Antigen Kinetic Screening for Rapid Biosimilar Downstream Processing Assessment

Demonstrating similarity of biomolecules such as antibodies throughout upstream and downstream production processes is crucial. A rapid testing method is demonstrated using a Humira® biosimilar (adalimumab) development sample, which assesses compatibility with three essential ligands in compliance with regulatory standards. This Application Note covers: How to rapidly assess column… Read More

#App Notes

#Therapeutic Antibodies

App Note: Biologics developability: How Merck creates developability profiles for their mAbs with Prometheus Panta

In this Application Note, discover how the Protein Sciences group at Merck & Co. builds developability profiles for their monoclonal antibody variants.   Get an in-depth explanation of the experiments they set up to obtain parameters that help them decide which candidates have the best potential to reach the market, and how they… Read More

#App Notes

#Automation / robotics #Biosafety testing #Drug discovery

Bespoke biosafety: Building a custom biosafety cabinet

Simply having a biosafety cabinet (BSC) with large enough interior dimensions to house automation equipment is not always sufficient for ensuring proper airflow and adequate protection. In many cases, the equipment may actually interfere with the cabinet’s airflow, creating turbulence and rendering the cabinet ineffective. Download this whitepaper about customised… Read More

#Resources

#Drug development #Drug discovery #Environmental impact #Guide #Lab of the future #Sustainability

Sustainability in the Lab: A Step-by-Step Guide

Download this guide to gain insights on the steps you can take to achieve a more sustainable lab without compromising quality or performance. Learn about: Conducting an assessment Choosing the right equipment Conserving water and reducing waste Engaging and educating your team… Read More

#Resources

#ALS #Drug discovery #Human disease models #iPSC #Neurology #Pluripotent stem cells #Stem cells

Using patient-specific cells for disease modelling

Induced pluripotent stem cell (iPSC)-derived cells are a significant resource for disease modelling. They allow the use of cells directly from affected patients and have the potential to guide these cells towards multiple lineages. Download the whitepaper to: Explore iPSC-derived motor neuron morphology Discover how ALS disease phenotype… Read More

#Resources